Mitesh

NHS Business Services Authority (NHSBSA) has identified a very small number of pharmacies that are declaring consistently and significantly above their actual number of prescription items dispensed each month when submitting their FP34C declaration via the Manage Your Service (MYS) portal. Given the Government’s obligations for Managing Public Money, the Department of Health and Social [...]

The post Changes to Advance payments for pharmacies that consistently over-declare items on FP34C appeared first on Community Pharmacy England.

From 1 October 2025, generically written prescriptions for Tadalafil and Vardenafil preparations will no longer require the prescriber ‘SLS’ endorsement. However, the SLS endorsement requirements will continue to apply to the following branded versions – Cialis® and Levitra® which may only be ordered on NHS prescriptions issued for the treatment of erectile dysfunction in restricted circumstances. [...]

The post SLS endorsement requirements removed for Tadalafil and Vardenafil appeared first on Community Pharmacy England.

The NHS restrictions on prescribing of influenza antiviral treatments, Oseltamivir (Tamiflu®) and Zanamivir (Relenza®) have been relaxed to allow prescribing of these flu antivirals at any time of the year for patients in clinical at-risk groups as well as those who are at risk of severe illness and/or complications from flu if not treated. Previously, to [...]

The post Removal of prescribing restrictions on flu antivirals appeared first on Community Pharmacy England.

Community Pharmacy England on behalf of pharmacy owners made further applications to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), resulting in a further 43 new products being added to the ‘Drugs for which Discount is Not Deducted’ (DND) list from 1 October 2025. This takes the total [...]

The post 43 products added to the Discount Not Deducted (DND) list from October 2025 appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (23/09/2025) confirmed the following list of price concessions for September 2025: Drug Pack size Price concession Amiodarone 200mg tablets 28 £5.97 Co-careldopa 25mg/100mg tablets 100 £8.38 Co-codamol 30mg/500mg tablets 30 £1.23 Co-codamol 30mg/500mg tablets 100 £4.10 Esomeprazole 20mg gastro-resistant capsules 28 £4.95 Fenofibrate micronised 267mg capsules 28 £5.80 [...]

The post September 2025 Price Concessions 2nd Update appeared first on Community Pharmacy England.